Valsartan Drug Recall Notice
Valsartan Drug Recall Notice
On July 16, 2018, a voluntary recall of valsartan and valsartan/Hydrochlorothiazide (HCTZ) tablets was issued. This is a generic medication used to treat high blood pressure and heart failure. An impurity, N-nitrosodimethylamine (NDMA) was detected in some generic manufacturer’s products. NDMA is classified as a probable human carcinogen…. Read More
2019 HSA/HDHP Limits
The IRS has announced updated inflation-adjusted HSA contribution limits as well as Out-Of-Pocket Maximum (OOP) expenses for health benefit plans.
In 2019, the HSA contribution limit will have minor increases to $3,500 for a single (an increase of $50) and $7,000 for family (an increase of $100).
The minimum deductible for a high-deductive health plan will have no changes, however, maximum will increase to $6,750 for the single (an increase of $100) and $13,500 for family (an increase of $200).
The maximum OOP limits for non-grandfathered plans will increase to $7,900 for single and $15,800 for the family.
Articles & Announcements
CONFIDIO Ranks No. 452 on the 2020 Inc. 5000 With Three-Year Revenue Growth of 1014.66%
Health Alert Updates: COVID-19
Emerging Treatments for Peanut Allergies
CONFIDIO NAMED TO INC. 5000 LIST
HHS Deploys Strategy to Import Drugs From Canada
White House reversal on Proposal to Eliminate Drug Rebates and Pushing Discounts to Point-of-Sale
BBJ’s Employee Benefits Administrators Listing
Will the Rebate Bubble Burst?
Valsartan Drug Recall Notice
Pharmacy Benefits 2020: Ready to Spend Half of Your Medical Plan Budget on Rx?